COVID-19 Practice and Advocacy Resources

Updated October 21, 2020 at 11:30 AM ET

Experiencing COVID-19 related drug shortages, practice issues, or any other problems?
Share your comments and questions with us at


Commercial Payer Temporary Telehealth Policies - Updated July 28, 2020
The ACR has compiled a chart of the temporary changes that commercial payers have made to their telehealth policies.

Telehealth Frequently Asked Questions - Updated May 14, 2020
The Frequently Asked Questions (FAQs) resource is a companion to the ACR Telemedicine Provider Fact Sheet to assist rheumatologists and their staff locate answers to key questions on practice flow and coding/billing telehealth services. 

ACR Telemedicine Provider Fact Sheet - Updated July 20, 2020
The ACR’s Telemedicine Provider Fact Sheet provides coding and other practical guidance for ensuring proper reimbursement for telehealth services. 

Telehealth Quick Reference Guide - Updated May 6, 2020
The ACR quick reference coding guide is designed to assist rheumatologists and rheumatology professionals to navigate coding and billing for telehealth services. 

Template Letter to State Boards Regarding Malpractice Carriers - Updated May 1, 2020
The ACR has created a template letter that providers can use to reach out to their state medical boards to advocate for clearer directives on practicing telehealth across state lines.

States Waiving of Modifying Licensure Requirements for Telemedicine in Response to COVID-19 - Updated April 24, 2020
The ACR has compiled a chart of state modifications to licensure requirements enabling providers to conduct telehealth across state lines during the COVID-19 emergency.

Patient Resource: How to Navigate Telehealth - Updated April 11, 2020
The ACR has developed guidance for rheumatologists and rheumatology professionals talking to patients who have questions about remote or telehealth visits with their rheumatology provider during the COVID-19 pandemic.

Telehealth Vendor List - Updated April 2, 2020
The ACR list of vendors is designed to help navigate an increasingly crowded space to choose the telehealth company that best meets rheumatology practices specific operational needs and unique patient population.

Medical Malpractice Coverage for Telehealth Services - Updated March 27, 2020
The ACR has prepared a chart with information on malpractice coverage for telehealth services. Practices are encouraged to contact their carriers and confirm coverage.  

Practice Support

Support for Vaccines from the American College of Rheumatology: Information for Members to Share with Patients 
Vaccinations are in the news again due to the urgent need for new vaccines against SARS-CoV-2 (i.e., the novel coronavirus that causes COVID-19). Rheumatologists have a long history of recommending specific vaccinations to our patients. We anticipate that any vaccine against COVID-19 that is approved for use in the United States will have robust and extensive data showing that it is safe and effective. Once such a vaccine becomes available, the ACR will recommend that all eligible individuals, including our patients and co-workers, be vaccinated. This document contains additional information to share with patients about vaccinations.

Information from the American College of Rheumatology Regarding Vaccination Against SARS-CoV-2  
More than 165 vaccines against SARS-CoV-2 are under development worldwide with dozens already in human trials. It is likely that numerous vaccines will eventually be approved by the FDA for use in the United States, but limited supplies in the early stages may lead to the need for strategies to allocate these finite resources. This information from the ACR addresses vaccine development, allocation and patient education.

ACR "Essential Eight" for Minimizing Risk During the COVID-19 Pandemic 
The ACR has created a patient-facing resource on the essential eight things you can do to minimize your risk and the risk to others during the COVID-19 pandemic.

ACR Guidance on Hydroxychloroquine and Other Drug Shortages

ACR Guiding Principles for Scarce Resource Allocation During the COVID-19 Pandemic
The ACR offers recommendations regarding the allocation of several resources during the COVID-19 pandemic. All recommendations are based on current knowledge and are subject to revision as circumstances evolve.
Hydroxychloroquine (HCQ) - Updated August 26, 2020

Compounding Pharmacy Announcement 
Following FDA's authorization to allow compounding pharmacies to compound hydroxychloroquine (HCQ) for patients who have relied on this medication, the ACR has been working to help members quickly identify pharmacies that may have compounded HCQ.

Advice for Talking to Patients About Shortages of Hydroxychloroquine During the COVID-19 Pandemic - Updated May 2, 2020
The ACR has generated suggested talking points that rheumatology professionals may wish to consider when discussing the hydroxychloroquine shortage with patients.

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us